2018 Annual Meeting | C56 - Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing

Date Sunday 04/22/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Michael E. Shy, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to determine when to consider ordering genetic testing for patients with neuropathy, determine when testing is positive or negative and have an approach of what to do when results are inconclusive, and understand the different forms of next generation sequencing and the strengths and weaknesses of these forms.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
03:30 PM - 04:15 PM	Speaker	Interpreting Genetic Testing Results in Patients with Inherited Neuropathies Shawna Feely
04:15 PM - 05:00 PM	Speaker	Advances and Limits of Next Generation Sequencing Beyond Clinical Testing Stephan Zuchner, MD, FAAN
05:00 PM - 05:30 PM	Q&A	Case Presentations / Questions and Answers Shawna Feely, Stephan Zuchner, MD, FAAN

Faculty Disclosures
Michael E. Shy, MD, FAAN	Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Shawna Feely	Shawna Feely has nothing to disclose.
Stephan Zuchner, MD, FAAN	Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.